RACHEL BATES: Open Payments
NPI 1134905573 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,305 in 89 payments from 17 companies in 2025. Trend: 2023 $449 · 2024 $3,894 · 2025 $3,305
Food & beverage: $3,305
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $576 |
| UCB, Inc. | 12 | $540 |
| Regeneron Healthcare Solutions, Inc. | 8 | $509 |
| Galderma Laboratories, L.P. | 18 | $368 |
| Arcutis Biotherapeutics, Inc. | 4 | $300 |
| Organon LLC | 3 | $178 |
| Lilly USA, LLC | 4 | $168 |
| Novartis Pharmaceuticals Corporation | 3 | $161 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $156 |
| GENZYME CORPORATION | 2 | $97 |
Products named: DUPIXENT, Bimzelx, BOTOX, Zoryve, NEMLUVIO, VTAMA, EBGLYSS, Odomzo.
Industry payments across GA — which companies pay providers there.
